SECSONAR

$PRLD

Prelude Therapeutics Incorporated

NASDAQ

Director, 10% Owner bought $12.5M

Up 20% since last report

Insider cost basis

Insiders bought — stock holding above

+25.0%vs buy

Insider buy $4.44Now $5.55

Find before everyone else

SEC filings, insider trades & earnings for PRLD — in one place.